Literature DB >> 3413985

Sequence of the structural proteins of tick-borne encephalitis virus (western subtype) and comparative analysis with other flaviviruses.

C W Mandl1, F X Heinz, C Kunz.   

Abstract

Tick-borne encephalitis (TBE) virus (Western subtype strain Neudoerfl) was cloned and the sequence of 2450 nucleotides of the 5'-terminal region of the genome was determined. By amino acid sequencing and sequence comparisons with other flaviviruses the amino-termini of the structural proteins and protein NS1 were localized. Sequence homologies with other flaviviruses were determined and corresponded well to the established serological classification system of the Flavivirus family. N-Glycosylation sites were found to be conserved to a large extent among members of the same serological subgroup, but not between members of different subgroups. Hydrophilicity plots and sequence comparisons revealed that the TBE virus capsid protein exhibited features distinct from all other flaviviruses. Additionally, the capsid protein coding region of another natural isolate of TBE virus (strain ZZ-9) was sequenced in order to analyze why the capsid protein of this strain exhibited a significantly faster migration rate on SDS-polyacrylamide gels than other TBE virus strains.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3413985     DOI: 10.1016/0042-6822(88)90161-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  53 in total

1.  Mapping of functional elements in the stem-anchor region of tick-borne encephalitis virus envelope protein E.

Authors:  S L Allison; K Stiasny; K Stadler; C W Mandl; F X Heinz
Journal:  J Virol       Date:  1999-07       Impact factor: 5.103

2.  Role of metastability and acidic pH in membrane fusion by tick-borne encephalitis virus.

Authors:  K Stiasny; S L Allison; C W Mandl; F X Heinz
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

3.  Capsid protein C of tick-borne encephalitis virus tolerates large internal deletions and is a favorable target for attenuation of virulence.

Authors:  Regina M Kofler; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

4.  Folding and dimerization of tick-borne encephalitis virus envelope proteins prM and E in the endoplasmic reticulum.

Authors:  Ivo C Lorenz; Steven L Allison; Franz X Heinz; Ari Helenius
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

5.  Spontaneous mutations restore the viability of tick-borne encephalitis virus mutants with large deletions in protein C.

Authors:  Regina M Kofler; Agnes Leitner; Gabriel O'Riordain; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

6.  Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus.

Authors:  Ivo C Lorenz; Jürgen Kartenbeck; Anna Mezzacasa; Steven L Allison; Franz X Heinz; Ari Helenius
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

7.  Incorporation of tick-borne encephalitis virus replicons into virus-like particles by a packaging cell line.

Authors:  Rainer Gehrke; Michael Ecker; Stephan W Aberle; Steven L Allison; Franz X Heinz; Christian W Mandl
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

8.  Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus.

Authors:  Steven L Allison; Yizhi J Tao; Gabriel O'Riordain; Christian W Mandl; Stephen C Harrison; Franz X Heinz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

9.  Mutational analysis of the octapeptide sequence motif at the NS1-NS2A cleavage junction of dengue type 4 virus.

Authors:  M Pethel; B Falgout; C J Lai
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

10.  Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins.

Authors:  B Falgout; M Pethel; Y M Zhang; C J Lai
Journal:  J Virol       Date:  1991-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.